Go Deep
Gilead Sciences, Inc.
Gilead Sciences, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 8,411 | -54.6 | 15.17 | 2.23 | 13,922.09 |
| Oct 2026 | 8,411 | -54.6 | 15.17 | 2.23 | 13,920.66 |
| Oct 2026 | 8,411 | -54.6 | 15.17 | 2.23 | 13,920.66 |
| Oct 2026 | 8,420 | -54.6 | 15.16 | 2.23 | 13,910.08 |
| Oct 2026 | 8,204 | -54.4 | 15.12 | 2.23 | 13,906.38 |
| Oct 2026 | 8,204 | -54.6 | 15.12 | 2.23 | 13,906.38 |
| Oct 2026 | 7,983 | -55.4 | 15.39 | 2.23 | 14,176.28 |
| Oct 2026 | 7,962 | -55.5 | 15.42 | 2.23 | 14,200.42 |
| Oct 2026 | 7,867 | -57.0 | 15.85 | 2.23 | 14,626.67 |
| Oct 2026 | 7,929 | -56.8 | 15.77 | 2.23 | 14,402.25 |
| Oct 2026 | 9,258 | -55.8 | 15.51 | 2.23 | 14,086.97 |
| Oct 2026 | 8,783 | -57.9 | 16.10 | 2.23 | 14,578.24 |
| Oct 2026 | 8,562 | -57.2 | 16.50 | 2.23 | 14,944.02 |
| Oct 2026 | 8,659 | -58.9 | 16.37 | 2.23 | 14,793.53 |
| Oct 2026 | 8,920 | -57.8 | 16.05 | 2.23 | 14,513.54 |
| Oct 2026 | 8,632 | -59.1 | 16.41 | 2.23 | 14,839.71 |
| Oct 2026 | 8,878 | -58.0 | 16.10 | 2.23 | 14,524.98 |
| Oct 2026 | 8,575 | -59.3 | 16.48 | 2.23 | 14,837.29 |
| Oct 2026 | 8,671 | -58.9 | 16.36 | 2.23 | 14,789.81 |
Gilead Sciences, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 7,803,000,000.0 | 6,960,000,000.0 | 7,924,000,000.0 | 7,769,000,000.0 |
| Net Profit | -10,496,000,000.0 | 2,021,000,000.0 | 2,183,000,000.0 | 3,052,000,000.0 |
| EPS | -8.4 | 1.6 | 1.8 | 2.5 |
Gilead Sciences, Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 29,442,000,000.0 | 28,754,000,000.0 | 27,116,000,000.0 | 27,281,000,000.0 |
| Net Profit | 8,510,000,000.0 | 480,000,000.0 | 5,665,000,000.0 | 4,592,000,000.0 |
| EPS | 6.8 | 0.4 | 4.5 | 3.7 |
Gilead Sciences, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 59,023,000,000.0 | 58,995,000,000.0 | 62,125,000,000.0 | 63,171,000,000.0 | — |
| Total Liabilities | 36,405,000,000.0 | 39,749,000,000.0 | 39,376,000,000.0 | 41,962,000,000.0 | — |
| Total Equity | 22,702,000,000.0 | 19,330,000,000.0 | 22,833,000,000.0 | 21,240,000,000.0 | — |
Owes vs Owns
Gilead Sciences, Inc. owed $0.76 for every $1 it owned in Jun 2026, up from $0.66 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.76× | 0.62× | 0.67× | 0.63× | 0.66× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Gilead Sciences, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 16.3%Receivables 8.3%Inventory 3.0%Fixed assets (tangible) 9.5%Intangible assets 42.9%Long-term investments 5.0%Other assets 15.0%
How it's funded — Dec 2025
Short-term debt 4.8%Long-term debt 37.5%Payables 1.2%Other liabilities 18.2%Shareholders' equity 38.3%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 9,613.0 | 11,568.0 | 7,264.0 | 6,385.0 |
| Receivables | 4,913.0 | 4,420.0 | 4,660.0 | 4,777.0 |
| Inventory | 1,774.0 | 1,710.0 | 1,787.0 | 1,507.0 |
| Fixed assets (tangible) | 5,606.0 | 5,414.0 | 5,317.0 | 5,475.0 |
| Intangible assets | 25,292.0 | 28,262.0 | 34,768.0 | 37,207.0 |
| Long-term investments | 2,974.0 | 0.0 | 1,163.0 | 1,245.0 |
| Other assets | 8,851.0 | 7,621.0 | 7,166.0 | 6,575.0 |
| Liabilities & equity | ||||
| Short-term debt | 2,807.0 | 1,815.0 | 1,798.0 | 2,273.0 |
| Long-term debt | 22,129.0 | 24,896.0 | 23,189.0 | 22,957.0 |
| Payables | 715.0 | 833.0 | 550.0 | 905.0 |
| Other liabilities | 10,754.0 | 12,205.0 | 13,839.0 | 15,827.0 |
| Shareholders' equity | 22,618.0 | 19,246.0 | 22,749.0 | 21,209.0 |
| Net tangible assets | -2,590.0 | -8,932.0 | -11,935.0 | -15,967.0 |
Gilead Sciences, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 10,019,000,000.0 | 10,828,000,000.0 | 8,006,000,000.0 | 9,072,000,000.0 | — |
| Investing Activities | -4,793,000,000.0 | -3,449,000,000.0 | -2,265,000,000.0 | -2,466,000,000.0 | — |
| Financing Activities | -7,745,000,000.0 | -3,433,000,000.0 | -5,125,000,000.0 | -6,469,000,000.0 | — |